期刊文献+

抗肿瘤药泰克地那林的合成工艺改进 被引量:3

Improved synthesis of tacedinaline,a new antitumour drug
下载PDF
导出
摘要 以 4 乙酰氨基苯甲酸 (2 )为原料 ,与草酰氯反应 ,不经分离 ,直接与 2 硝基苯胺反应得到中间体N (2 硝基苯基 ) 4 乙酰氨基苯甲酰胺 (4 ) ,再经催化氢化得到泰克地那林。以 4 乙酰氨基苯甲酸计 ,总收率为 2 2 2 % ,目标化合物的结构经质谱、红外光谱及核磁共振氢谱确证 ,该合成工艺简单易行。 Tacedinaline was synthesized from 4-(acetamido)benzoic acid by the reaction with oxalyl chloride to form 4-(acetamido)benzoyl chloride which was condensed with 2-nitroaniline,followed by reduction with H 2 over Pd/C.The overall yield of the improved procedure was 22.2%.The structure of tacedinaline was confirmed by IR,MS and 1H-NMR,and the process is simpler and more practical.
出处 《中国药物化学杂志》 CAS CSCD 2004年第4期247-248,共2页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 工艺改进 工艺研究 泰克地那林 medicinal chemistry process improvement process research tacedinaline
  • 相关文献

参考文献3

  • 1Graul A,Leeson P,Castaner J.CI-994[J].Drugs Fut,1997,22(11):1201-1204.
  • 2Ian Lloyd.Tacedinaline[J].Pharma Projects(Therapeutic Main Volume,K6Z),2003,24:a2763-2764.
  • 3Weirshausen U,Satzinger G,Vollmer KO,et al.N-(2-aminophenyl)-benzamide derivatives process for the preparation thereof and pharmaceutical compositions containing them[P].US:5137918,1992-08-11.

同被引文献13

  • 1刘剑,张丽丽,汪运山,付传芸.增强型酶催化发光免疫分析法高灵敏测定血清中心肌肌钙蛋白Ⅰ[J].发光学报,2014,35(4):506-510. 被引量:2
  • 2Gridelli C ,Rossi A,Maione P. The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer [ J ]. Crit Rev Oncol Hernatol, 2008, 68( 1 ) :29.
  • 3Thomas M, Clarhaut J, Tranoy-Opalinski I ,et al. Synthesis and bio- logical evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy [ J ] . Bioorg Med Chem ,2008 , 16(17) :8109.
  • 4Weirshausen U, Satzinger G,Vollmer KO, et al. N-(2-aminophe- nyl)-benzamide derivatives process for the preparation thereof and pharmaceutical compositions containing them [ P ]. US, 5137918. 1992-08-11.
  • 5GRIDELLI C, ROSSI A, MAIONE P. The potential role of histone deacetylase inhibitors in the treatment of non- small-cell lung cancer [ J ]. Crit Rev Oncol Hematol, 2008, 68 ( 1 ) : 29 - 36.
  • 6GRAUL A, LEESON P, CASTANER J. CI-994, Antine-oplastic [J]. Drugs Fut, 1997, 22(11) : 1201 - 1204.
  • 7LLOYD I. Tacedinaline [ J ]. Pharma Projects ( Thera- peutic Main Volume, K6Z), 2003, 24 : a2763 - a2764.
  • 8WEIRSHAUSEN U, SATZINGER G, VOLLMER K O, et al. N-(2-aminophenyl)-benzamide derivatives process for the preparation thereof and pharmaceutical composi- tions containing them [ P]. US: 5137918, 1992 - 08 - 11.
  • 9刘靖,王林,温晓雪,曾凡奇,杨林.抗肿瘤药物泰克地那林的合成研究[J].解放军药学学报,2009,25(4):343-344. 被引量:1
  • 10汪晨,吴洁,宗晨,徐洁,鞠熀先.化学发光免疫分析方法与应用进展[J].分析化学,2012,40(1):3-10. 被引量:63

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部